Treating the Partners of Drug Using Pregnant Women: Stage II

Johns Hopkins University158 enrolled

Overview

This is a two group randomized design that will compare a novel therapy package (i.e., Research supported treatment intervention, Contingency-based voucher incentives for the male partner's drug abstinence, Specialized MI couples counseling) to standard care for helping drug using partners of drug dependent pregnant women obtain and maintain drug abstinence. Participants will be followed for 22 weeks and have scheduled twice weekly urine sample collection and all participants will have follow-up interviews post-study entry.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

158

Conditions

Drug Addiction

Interventions

Enhanced careBEHAVIORAL

this group received counseling, contingency management and methadone or detoxification

controlBEHAVIORAL

this group receives the opportunity to participate in a support group

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * are 18 years of age or older on admission; * Pregnant as determined by sonogram results * have a current sexual partner who they have seen recently at least 3 times a week * male partner has regular alcohol or illicit drug use (at least 4 of 7 days typical use) and is not incarcerated. Exclusion Criteria: * woman or partner report current suicidal ideation * woman or partner meet diagnostic criteria for a current DSM-IV Axis I thought disorder (i.e. schizophrenia) * woman or partner demonstrate significant cognitive impairment that precludes them from completing the initial assessment battery * woman has evidence of physical violence or abuse

Locations (1)

Center for Addiction and Pregnancy Johns Hopkins Bayview Medical Center

Baltimore, Maryland, United States

Outcomes

Primary Outcomes

Partner Objective Substance Use

Time frame: treatment entry until 28 weeks later

Secondary Outcomes

Woman's drug use will be measured with urine toxicology

Time frame: treatment entry until 28 weeks later

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.